BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

BiomX

BiomX logo

Founded
2015
Patents
6
Clinical Trials
3
Publications
7

Technologies

Microbiome Startups

BiomX discovers and develops innovative microbiome therapeutics. The Company's mission is to develop novel therapeutics for preventing and treating diseases in which microbiome imbalances have been implicated. BiomX's microbiome modulation technologies are based on the cutting-edge innovative research of its scientific collaborators: Professor Rotem Sorek, PhD and Dr. Eran Elinav, MD, PhD both of the Weizmann Institute of Science and Professor Timothy K. Lu, MD, PhD of the Massachusetts Institute of Technology.


Posts Mentioning This Company

Microbiome: Can Human Microbes Become A Panacea?

  
The microbiome is implicated in a number of metabolic pathways and communicates closely with our body in health and diseases. Imbalance of microflora is linked to obesity, diabetes, allergies, cancer, and even depression and autism. However, these facts have been ignored for decades. But today, the microbiome market is catching …